Salarius Pharmaceuticals, Inc. — Director's Dealing 2016

Mar 25, 2016

SEC Form 4/A — Form 4/A

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2016-03-22

Reporting Person: Westphal Christoph H (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-22	Common Stock	P	23951	$11.78	Acquired	2910955	Indirect